Syveroxme

Cefuroxime Axetil is the orally active prodrug of Cefuroxime, a second-generation cephalosporin antibiotic used in the treatment of bacterial infections such as respiratory tract infections, otitis media, urinary tract infections, and skin infections. Upon oral administration, it is hydrolyzed in the gastrointestinal tract to release the active form, Cefuroxime, which inhibits bacterial cell wall synthesis. Supplied as a white to off-white crystalline powder, Cefuroxime Axetil is used primarily in tablet and suspension formulations. It is manufactured under GMP-compliant conditions and complies with international pharmacopeial standards (USP/BP/EP). Full regulatory documentation, including DMFs and CTD dossiers, is available to support global filings.